Geode Capital Management, LLC Sellas Life Sciences Group, Inc. Transaction History
Geode Capital Management, LLC
- $1.39 Trillion
- Q2 2025
A detailed history of Geode Capital Management, LLC transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,200,428 shares of SLS stock, worth $3.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,200,428
Previous 820,440
168.2%
Holding current value
$3.7 Million
Previous $886,000
443.79%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding SLS
# of Institutions
84Shares Held
22.6MCall Options Held
1.3MPut Options Held
59.3K-
Vanguard Group Inc Valley Forge, PA6.65MShares$11.2 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.72MShares$4.56 Million0.01% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA1.49MShares$2.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.13MShares$1.89 Million0.0% of portfolio
-
State Street Corp Boston, MA1.11MShares$1.87 Million0.0% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $34.5M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...